1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Exosome Therapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Direct Treatment
1.2.3 Drug Delivery Vehicle
1.3 Market by Application
1.3.1 Global Exosome Therapy Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institutions
1.4 Study Objectives
1.5 Years Considered 2 Global Growth Trends
2.1 Global Exosome Therapy Market Perspective (2017-2028)
2.2 Exosome Therapy Growth Trends by Region
2.2.1 Exosome Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Exosome Therapy Historic Market Size by Region (2017-2022)
2.2.3 Exosome Therapy Forecasted Market Size by Region (2023-2028)
2.3 Exosome Therapy Market Dynamics
2.3.1 Exosome Therapy Industry Trends
2.3.2 Exosome Therapy Market Drivers
2.3.3 Exosome Therapy Market Challenges
2.3.4 Exosome Therapy Market Restraints 3 Competition Landscape by Key Players
3.1 Global Top Exosome Therapy Players by Revenue
3.1.1 Global Top Exosome Therapy Players by Revenue (2017-2022)
3.1.2 Global Exosome Therapy Revenue Market Share by Players (2017-2022)
3.2 Global Exosome Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Exosome Therapy Revenue
3.4 Global Exosome Therapy Market Concentration Ratio
3.4.1 Global Exosome Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Exosome Therapy Revenue in 2021
3.5 Exosome Therapy Key Players Head office and Area Served
3.6 Key Players Exosome Therapy Product Solution and Service
3.7 Date of Enter into Exosome Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans 4 Exosome Therapy Breakdown Data by Type
4.1 Global Exosome Therapy Historic Market Size by Type (2017-2022)
4.2 Global Exosome Therapy Forecasted Market Size by Type (2023-2028) 5 Exosome Therapy Breakdown Data by Application
5.1 Global Exosome Therapy Historic Market Size by Application (2017-2022)
5.2 Global Exosome Therapy Forecasted Market Size by Application (2023-2028) 6 North America
6.1 North America Exosome Therapy Market Size (2017-2028)
6.2 North America Exosome Therapy Market Size by Country (2017-2022)
6.3 North America Exosome Therapy Market Size by Country (2023-2028)
6.4 United States
6.5 Canada 7 Europe
7.1 Europe Exosome Therapy Market Size (2017-2028)
7.2 Europe Exosome Therapy Market Size by Country (2017-2022)
7.3 Europe Exosome Therapy Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries 8 Asia-Pacific
8.1 Asia-Pacific Exosome Therapy Market Size (2017-2028)
8.2 Asia-Pacific Exosome Therapy Market Size by Country (2017-2022)
8.3 Asia-Pacific Exosome Therapy Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia 9 Latin America
9.1 Latin America Exosome Therapy Market Size (2017-2028)
9.2 Latin America Exosome Therapy Market Size by Country (2017-2022)
9.3 Latin America Exosome Therapy Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil 10 Middle East & Africa
10.1 Middle East & Africa Exosome Therapy Market Size (2017-2028)
10.2 Middle East & Africa Exosome Therapy Market Size by Country (2017-2022)
10.3 Middle East & Africa Exosome Therapy Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE 11 Key Players Profiles
11.1 United Therapeutics Corporation
11.1.1 United Therapeutics Corporation Company Detail
11.1.2 United Therapeutics Corporation Business Overview
11.1.3 United Therapeutics Corporation Exosome Therapy Introduction
11.1.4 United Therapeutics Corporation Revenue in Exosome Therapy Business (2017-2022)
11.1.5 United Therapeutics Corporation Recent Development
11.2 Codiak BioSciences
11.2.1 Codiak BioSciences Company Detail
11.2.2 Codiak BioSciences Business Overview
11.2.3 Codiak BioSciences Exosome Therapy Introduction
11.2.4 Codiak BioSciences Revenue in Exosome Therapy Business (2017-2022)
11.2.5 Codiak BioSciences Recent Development
11.3 EngEx?
11.3.1 EngEx? Company Detail
11.3.2 EngEx? Business Overview
11.3.3 EngEx? Exosome Therapy Introduction
11.3.4 EngEx? Revenue in Exosome Therapy Business (2017-2022)
11.3.5 EngEx? Recent Development
11.4 Esperite Group
11.4.1 Esperite Group Company Detail
11.4.2 Esperite Group Business Overview
11.4.3 Esperite Group Exosome Therapy Introduction
11.4.4 Esperite Group Revenue in Exosome Therapy Business (2017-2022)
11.4.5 Esperite Group Recent Development
11.5 ArunA Biomedical
11.5.1 ArunA Biomedical Company Detail
11.5.2 ArunA Biomedical Business Overview
11.5.3 ArunA Biomedical Exosome Therapy Introduction
11.5.4 ArunA Biomedical Revenue in Exosome Therapy Business (2017-2022)
11.5.5 ArunA Biomedical Recent Development
11.6 Evox Therapeutics
11.6.1 Evox Therapeutics Company Detail
11.6.2 Evox Therapeutics Business Overview
11.6.3 Evox Therapeutics Exosome Therapy Introduction
11.6.4 Evox Therapeutics Revenue in Exosome Therapy Business (2017-2022)
11.6.5 Evox Therapeutics Recent Development
11.7 NeurExo Sciences
11.7.1 NeurExo Sciences Company Detail
11.7.2 NeurExo Sciences Business Overview
11.7.3 NeurExo Sciences Exosome Therapy Introduction
11.7.4 NeurExo Sciences Revenue in Exosome Therapy Business (2017-2022)
11.7.5 NeurExo Sciences Recent Development
11.8 Tavec Pharmaceuticals
11.8.1 Tavec Pharmaceuticals Company Detail
11.8.2 Tavec Pharmaceuticals Business Overview
11.8.3 Tavec Pharmaceuticals Exosome Therapy Introduction
11.8.4 Tavec Pharmaceuticals Revenue in Exosome Therapy Business (2017-2022)
11.8.5 Tavec Pharmaceuticals Recent Development
11.9 AEGLE Therapeutics
11.9.1 AEGLE Therapeutics Company Detail
11.9.2 AEGLE Therapeutics Business Overview
11.9.3 AEGLE Therapeutics Exosome Therapy Introduction
11.9.4 AEGLE Therapeutics Revenue in Exosome Therapy Business (2017-2022)
11.9.5 AEGLE Therapeutics Recent Development
11.10 Avalon GloboCare
11.10.1 Avalon GloboCare Company Detail
11.10.2 Avalon GloboCare Business Overview
11.10.3 Avalon GloboCare Exosome Therapy Introduction
11.10.4 Avalon GloboCare Revenue in Exosome Therapy Business (2017-2022)
11.10.5 Avalon GloboCare Recent Development
11.11 AlligatorBioscience
11.11.1 AlligatorBioscience Company Detail
11.11.2 AlligatorBioscience Business Overview
11.11.3 AlligatorBioscience Exosome Therapy Introduction
11.11.4 AlligatorBioscience Revenue in Exosome Therapy Business (2017-2022)
11.11.5 AlligatorBioscience Recent Development
11.12 Capricor Therapeutics
11.12.1 Capricor Therapeutics Company Detail
11.12.2 Capricor Therapeutics Business Overview
11.12.3 Capricor Therapeutics Exosome Therapy Introduction
11.12.4 Capricor Therapeutics Revenue in Exosome Therapy Business (2017-2022)
11.12.5 Capricor Therapeutics Recent Development
11.13 Stem Cell Medicine
11.13.1 Stem Cell Medicine Company Detail
11.13.2 Stem Cell Medicine Business Overview
11.13.3 Stem Cell Medicine Exosome Therapy Introduction
11.13.4 Stem Cell Medicine Revenue in Exosome Therapy Business (2017-2022)
11.13.5 Stem Cell Medicine Recent Development
11.14 CellTex Therapeutics
11.14.1 CellTex Therapeutics Company Detail
11.14.2 CellTex Therapeutics Business Overview
11.14.3 CellTex Therapeutics Exosome Therapy Introduction
11.14.4 CellTex Therapeutics Revenue in Exosome Therapy Business (2017-2022)
11.14.5 CellTex Therapeutics Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
